Lilly Taps AI for Alzheimer’s Research with SpeechDx
Some folks might just brush off a little forgetfulness as old age, but what if we could pinpoint Alzheimer's up front with just the way someone talks? That’s the big league play Eli Lilly's making by licensing the SpeechDx dataset from the Alzheimer's Drug Discovery Foundation (ADDF). This ain't your run-of-the-mill data—it's the largest harmonized longitudinal...
Continue Reading